Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT06472830

MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study

Conditions: Monoclonal Gammopathy of Undetermined Significance

Sex: All
Ages: 40 Years – N/A
Healthy volunteers: Yes
Enrollment: 1000
Sponsor: Mayo Clinic

Location: Mayo Clinic in Rochester Rochester Minnesota

Summary

This study is being done to screen adults for MGUS and to better understand the genetic and immune factors linked to this condition. Monoclonal gammopathy of undetermined significance or MGUS is a condition where an abnormal immune protein is found in the blood. MGUS is not cancer. In some people, it slowly develops into a blood cancer called multiple myeloma. MGUS occurs in people from all backgrounds. Researchers hope to use the information from this study to improve knowledge, early detection, and future care for everyone.

Eligibility Criteria

Inclusion Criteria: * Adults ≥ 40 years * Willing and able to review, understand, and provide consent before starting any study-specific procedures * Ability to complete questionnaire(s) by themselves or with assistance Exclusion Criteria: * Pregnant women

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06472830). StuddyBuddy aggregates publicly available trial information.